NO920395D0 - Terapeutisk aktive benzyloksyfenyl-derivater og fremgangsmaate for deres fremstilling - Google Patents
Terapeutisk aktive benzyloksyfenyl-derivater og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO920395D0 NO920395D0 NO920395A NO920395A NO920395D0 NO 920395 D0 NO920395 D0 NO 920395D0 NO 920395 A NO920395 A NO 920395A NO 920395 A NO920395 A NO 920395A NO 920395 D0 NO920395 D0 NO 920395D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutic active
- benzyloxyphenyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4103003 | 1991-02-01 | ||
| DE4110478 | 1991-03-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO920395D0 true NO920395D0 (no) | 1992-01-30 |
| NO920395L NO920395L (no) | 1992-08-03 |
Family
ID=25900677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920395A NO920395L (no) | 1991-02-01 | 1992-01-30 | Terapeutisk aktive benzyloksyfenyl-derivater og fremgangsmaate for deres fremstilling |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0497740B1 (no) |
| JP (1) | JPH0570400A (no) |
| AT (1) | ATE115541T1 (no) |
| AU (1) | AU1058492A (no) |
| CA (1) | CA2060352A1 (no) |
| CS (1) | CS27892A3 (no) |
| DE (1) | DE69200863D1 (no) |
| FI (1) | FI920430A (no) |
| HU (1) | HUT60458A (no) |
| IE (1) | IE920335A1 (no) |
| IL (1) | IL100805A0 (no) |
| MX (1) | MX9200396A (no) |
| NO (1) | NO920395L (no) |
| NZ (1) | NZ241467A (no) |
| RO (1) | RO107405B1 (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124343A (en) * | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
| GB9121943D0 (en) * | 1991-10-16 | 1991-11-27 | Sandoz Ltd | Organic compounds,processes for their production and their use |
| CN1056599C (zh) * | 1993-01-01 | 2000-09-20 | 诺瓦蒂斯有限公司 | 双(苯基)乙烷衍生物 |
| KR100437580B1 (ko) * | 1995-03-14 | 2004-07-16 | 노파르티스 아게 | 삼치환된페닐유도체 |
| JP3081773B2 (ja) * | 1995-03-31 | 2000-08-28 | 株式会社資生堂 | Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤 |
| JP4189043B2 (ja) * | 1996-09-30 | 2008-12-03 | 株式会社資生堂 | Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤 |
| JP4697962B2 (ja) | 2003-02-13 | 2011-06-08 | ウェルスタット セラピューティクス コーポレイション | 代謝性障害の処置のための化合物 |
| US7741352B2 (en) * | 2003-03-11 | 2010-06-22 | Neurosearch A/S | KCNQ channel modulating compounds and their pharmaceutical use |
| SE0400234D0 (sv) * | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
| SE0400235D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
| US8314124B2 (en) | 2004-02-06 | 2012-11-20 | Active Biotech Ab | Crystalline salts of quinoline compounds and methods for preparing them |
| JP5832716B2 (ja) | 2005-10-19 | 2015-12-16 | テバ ファーマシューティカル インダストリーズ リミティド | ラキニモドナトリウムの結晶，及びその製造方法 |
| SI2035001T1 (sl) | 2006-06-12 | 2012-03-30 | Teva Pharma | Stabilni pripravki lakvinimoda |
| AU2008213147A1 (en) * | 2007-02-06 | 2008-08-14 | Chelsea Therapeutics, Inc. | New compounds, methods for their preparation and use thereof |
| PL2682120T3 (pl) | 2007-12-20 | 2017-02-28 | Teva Pharmaceutical Industries, Ltd. | Stabilne preparaty lakwinimodu |
| NZ591315A (en) | 2008-09-03 | 2012-08-31 | Teva Pharma | 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| CN102603544A (zh) * | 2012-04-06 | 2012-07-25 | 南京大学 | 一种抗炎化合物、其制备及其用途 |
| EP2916915A4 (en) | 2012-11-07 | 2016-06-22 | Teva Pharma | LAQUINIMOD AMINE SALTS |
| US9233927B2 (en) | 2013-03-14 | 2016-01-12 | Teva Pharmaceutical Industries, Ltd. | Crystals of laquinimod sodium and improved process for the manufacture thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5643717U (no) * | 1979-09-13 | 1981-04-21 | ||
| JPS5713418U (no) * | 1980-06-30 | 1982-01-23 | ||
| JPS5758013U (no) * | 1980-09-24 | 1982-04-06 | ||
| JPS6231017U (no) * | 1985-08-08 | 1987-02-24 | ||
| JPS6394112U (no) * | 1986-12-10 | 1988-06-17 | ||
| JPH0356519U (no) * | 1989-10-09 | 1991-05-30 |
-
1992
- 1992-01-22 HU HU9200204A patent/HUT60458A/hu unknown
- 1992-01-29 AT AT92810066T patent/ATE115541T1/de not_active IP Right Cessation
- 1992-01-29 DE DE69200863T patent/DE69200863D1/de not_active Expired - Lifetime
- 1992-01-29 EP EP92810066A patent/EP0497740B1/en not_active Expired - Lifetime
- 1992-01-30 NZ NZ241467A patent/NZ241467A/en unknown
- 1992-01-30 MX MX9200396A patent/MX9200396A/es unknown
- 1992-01-30 AU AU10584/92A patent/AU1058492A/en not_active Abandoned
- 1992-01-30 FI FI920430A patent/FI920430A/fi not_active Application Discontinuation
- 1992-01-30 CA CA002060352A patent/CA2060352A1/en not_active Abandoned
- 1992-01-30 IL IL100805A patent/IL100805A0/xx unknown
- 1992-01-30 CS CS92278A patent/CS27892A3/cs unknown
- 1992-01-30 NO NO92920395A patent/NO920395L/no unknown
- 1992-01-31 RO RO92-200051A patent/RO107405B1/ro unknown
- 1992-01-31 IE IE033592A patent/IE920335A1/en not_active Application Discontinuation
- 1992-01-31 JP JP4016084A patent/JPH0570400A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ241467A (en) | 1994-02-25 |
| DE69200863D1 (de) | 1995-01-26 |
| IL100805A0 (en) | 1992-09-06 |
| RO107405B1 (ro) | 1993-11-30 |
| NO920395L (no) | 1992-08-03 |
| FI920430A (fi) | 1992-08-02 |
| AU1058492A (en) | 1992-08-06 |
| HU9200204D0 (en) | 1992-04-28 |
| EP0497740B1 (en) | 1994-12-14 |
| ATE115541T1 (de) | 1994-12-15 |
| MX9200396A (es) | 1992-08-01 |
| EP0497740A1 (en) | 1992-08-05 |
| HUT60458A (en) | 1992-09-28 |
| CA2060352A1 (en) | 1992-08-02 |
| FI920430A0 (fi) | 1992-01-30 |
| JPH0570400A (ja) | 1993-03-23 |
| IE920335A1 (en) | 1992-08-12 |
| CS27892A3 (en) | 1992-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO920395D0 (no) | Terapeutisk aktive benzyloksyfenyl-derivater og fremgangsmaate for deres fremstilling | |
| SE9402558D0 (sv) | Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma | |
| BR0211228A (pt) | Composto, composição farmacêutica e seus usos | |
| NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
| MY102016A (en) | Thiazolidinedione derivatives, their production and use. | |
| NO992524L (no) | Konsenserte bicykliske pyrimidin-derivater | |
| DK0430045T3 (da) | Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion | |
| DK275488D0 (da) | Indolonderivater | |
| NO980313L (no) | N-(aroyl)glysin-hydroksaminsyre-derivater og beslektete forbindelser | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| ES2101858T3 (es) | Derivados de geneserina como inhibidores de colinesterasa. | |
| BR9807950A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto | |
| DE69413118D1 (de) | Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität | |
| DK513384D0 (da) | Griseolsyrederivater og deres anvendelse | |
| ATE114154T1 (de) | Thienotriazolodiazepine und ihre pharmazeutische verwendung. | |
| PH22213A (en) | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use | |
| NO982863L (no) | Nye forbindelser med analgetisk effekt | |
| SE8700555D0 (sv) | Purine derivatives, their production and medicaments containing them | |
| DE68922035D1 (de) | Glyzerin-Derivat und dessen pharmazeutische Verwendung. | |
| DE3880304D1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
| NO923983D0 (no) | Bisfenyletanderivater, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse | |
| DK270889D0 (da) | Cytostatisk virksomme anthracyclinderivater, deres fremstilling og anvendelse | |
| ES2073919T3 (es) | Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo. | |
| DE3884878D1 (de) | Uricosuretische Zusammensetzung. | |
| DE3575562D1 (de) | Triazolopyrimidinderivate. |